PUBLISHER: Prescient & Strategic Intelligence | PRODUCT CODE: 1643602
PUBLISHER: Prescient & Strategic Intelligence | PRODUCT CODE: 1643602
Transplantation Market Size & Share Analysis - Trends, Drivers, Competitive Landscape, and Forecasts (2025 - 2032)
The global transplantation market is projected to grow from $17.4 billion in 2024 to $36.1 billion by 2032, reflecting a compound annual growth rate (CAGR) of 9.7%. This growth is driven by the increasing incidence of chronic diseases, such as kidney failure, myelodysplastic disorders, solid tumors, immune system disorders, and plasma cell disorders. Additionally, rising awareness about organ donation, technological advancements like robot-assisted kidney transplants, and improvements in organ transportation success rates are contributing to market expansion.
Key Insights
Tissue products, including grafts and biological materials, are widely used in transplantation procedures to replace or repair damaged tissues. Immunosuppressive drugs are critical for preventing organ rejection by suppressing the immune response in transplant recipients. Preservation solutions are essential for maintaining the viability of organs and tissues between procurement and transplantation.
Tissue transplantation involves the replacement of damaged tissues such as skin, corneas, heart valves, bones, and tendons to restore function. Organ transplantation includes procedures involving vital organs like kidneys, liver, heart, lungs, and pancreas to treat end-stage organ failure.
Hospitals serve as primary centers for transplantation surgeries, equipped with the necessary facilities and expertise. Transplant centers are specialized institutions focused on conducting these procedures and providing comprehensive patient care.
North America holds the largest market share due to advanced healthcare infrastructure, high awareness levels, and government initiatives promoting organ donation. Asia-Pacific is expected to witness the fastest growth, driven by increasing healthcare expenditures, rising prevalence of chronic diseases, and growing awareness about organ donation and transplantation.
3D-printed organs are emerging as a transformative trend, offering potential solutions to organ shortages by creating artificial organs. Robot-assisted transplants enhance precision in surgeries, reduce recovery times, and improve patient outcomes.
The increasing prevalence of chronic diseases leading to organ failure is driving the demand for transplantation procedures. Government initiatives and awareness programs promoting organ donation and transplantation are facilitating market growth. Advancements in medical technology, including improved surgical techniques and preservation methods, are boosting success rates and demand.
Organ shortages remain a significant challenge, with demand far outstripping supply, resulting in longer waiting times for patients. Ethical and legal concerns surrounding organ procurement and allocation pose additional challenges for the market.
Table of Contents
Chapter 1. Research Scope
- 1.1. Research Objectives
- 1.2. Market Definition
- 1.3. Analysis Period
- 1.4. Market Size Breakdown by Segments
- 1.4.1. Market size breakdown, by product type
- 1.4.2. Market size breakdown, by application
- 1.4.3. Market size breakdown, by end user
- 1.4.4. Market size breakdown, by region
- 1.4.5. Market size breakdown, by country
- 1.5. Market Data Reporting Unit
- 1.5.1. Value
- 1.6. Key Stakeholders
Chapter 2. Research Methodology
- 2.1. Secondary Research
- 2.1.1. Paid
- 2.1.2. Unpaid
- 2.1.3. P&S Intelligence database
- 2.2. Primary Research
- 2.3. Market Size Estimation
- 2.4. Data Triangulation
- 2.5. Currency Conversion Rates
- 2.6. Assumptions for the Study
- 2.7. Notes and Caveats
Chapter 3. Executive Summary
Chapter 4. Market Indicators
Chapter 5. Industry Outlook
- 5.1. Market Dynamics
- 5.1.1. Trends
- 5.1.2. Drivers
- 5.1.3. Restraints/challenges
- 5.1.4. Impact analysis of drivers/restraints
- 5.2. Impact of COVID-19
- 5.3. Porter's Five Forces Analysis
- 5.3.1. Bargaining power of buyers
- 5.3.2. Bargaining power of suppliers
- 5.3.3. Threat of new entrants
- 5.3.4. Intensity of rivalry
- 5.3.5. Threat of substitutes
Chapter 6. Global Market
- 6.1. Overview
- 6.2. Market Revenue, by Product Type (2019-2032)
- 6.3. Market Revenue, by Application (2019-2032)
- 6.4. Market Revenue, by End User (2019-2032)
- 6.5. Market Revenue, by Region (2019-2032)
Chapter 7. North America Market
- 7.1. Overview
- 7.2. Market Revenue, by Product Type (2019-2032)
- 7.3. Market Revenue, by Application (2019-2032)
- 7.4. Market Revenue, by End User (2019-2032)
- 7.5. Market Revenue, by Country (2019-2032)
Chapter 8. Europe Market
- 8.1. Overview
- 8.2. Market Revenue, by Product Type (2019-2032)
- 8.3. Market Revenue, by Application (2019-2032)
- 8.4. Market Revenue, by End User (2019-2032)
- 8.5. Market Revenue, by Country (2019-2032)
Chapter 9. APAC Market
- 9.1. Overview
- 9.2. Market Revenue, by Product Type (2019-2032)
- 9.3. Market Revenue, by Application (2019-2032)
- 9.4. Market Revenue, by End User (2019-2032)
- 9.5. Market Revenue, by Country (2019-2032)
Chapter 10. LATAM Market
- 10.1. Overview
- 10.2. Market Revenue, by Product Type (2019-2032)
- 10.3. Market Revenue, by Application (2019-2032)
- 10.4. Market Revenue, by End User (2019-2032)
- 10.5. Market Revenue, by Country (2019-2032)
Chapter 11. MEA Market
- 11.1. Overview
- 11.2. Market Revenue, by Product Type (2019-2032)
- 11.3. Market Revenue, by Application (2019-2032)
- 11.4. Market Revenue, by End User (2019-2032)
- 11.5. Market Revenue, by Country (2019-2032)
Chapter 12. U.S. Market
- 12.1. Overview
- 12.2. Market Revenue, by Product Type (2019-2032)
- 12.3. Market Revenue, by Application (2019-2032)
- 12.4. Market Revenue, by End User (2019-2032)
Chapter 13. Canada Market
- 13.1. Overview
- 13.2. Market Revenue, by Product Type (2019-2032)
- 13.3. Market Revenue, by Application (2019-2032)
- 13.4. Market Revenue, by End User (2019-2032)
Chapter 14. Germany Market
- 14.1. Overview
- 14.2. Market Revenue, by Product Type (2019-2032)
- 14.3. Market Revenue, by Application (2019-2032)
- 14.4. Market Revenue, by End User (2019-2032)
Chapter 15. France Market
- 15.1. Overview
- 15.2. Market Revenue, by Product Type (2019-2032)
- 15.3. Market Revenue, by Application (2019-2032)
- 15.4. Market Revenue, by End User (2019-2032)
Chapter 16. U.K. Market
- 16.1. Overview
- 16.2. Market Revenue, by Product Type (2019-2032)
- 16.3. Market Revenue, by Application (2019-2032)
- 16.4. Market Revenue, by End User (2019-2032)
Chapter 17. Italy Market
- 17.1. Overview
- 17.2. Market Revenue, by Product Type (2019-2032)
- 17.3. Market Revenue, by Application (2019-2032)
- 17.4. Market Revenue, by End User (2019-2032)
Chapter 18. Spain Market
- 18.1. Overview
- 18.2. Market Revenue, by Product Type (2019-2032)
- 18.3. Market Revenue, by Application (2019-2032)
- 18.4. Market Revenue, by End User (2019-2032)
Chapter 19. Japan Market
- 19.1. Overview
- 19.2. Market Revenue, by Product Type (2019-2032)
- 19.3. Market Revenue, by Application (2019-2032)
- 19.4. Market Revenue, by End User (2019-2032)
Chapter 20. China Market
- 20.1. Overview
- 20.2. Market Revenue, by Product Type (2019-2032)
- 20.3. Market Revenue, by Application (2019-2032)
- 20.4. Market Revenue, by End User (2019-2032)
Chapter 21. India Market
- 21.1. Overview
- 21.2. Market Revenue, by Product Type (2019-2032)
- 21.3. Market Revenue, by Application (2019-2032)
- 21.4. Market Revenue, by End User (2019-2032)
Chapter 22. Australia Market
- 22.1. Overview
- 22.2. Market Revenue, by Product Type (2019-2032)
- 22.3. Market Revenue, by Application (2019-2032)
- 22.4. Market Revenue, by End User (2019-2032)
Chapter 23. South Korea Market
- 23.1. Overview
- 23.2. Market Revenue, by Product Type (2019-2032)
- 23.3. Market Revenue, by Application (2019-2032)
- 23.4. Market Revenue, by End User (2019-2032)
Chapter 24. Brazil Market
- 24.1. Overview
- 24.2. Market Revenue, by Product Type (2019-2032)
- 24.3. Market Revenue, by Application (2019-2032)
- 24.4. Market Revenue, by End User (2019-2032)
Chapter 25. Mexico Market
- 25.1. Overview
- 25.2. Market Revenue, by Product Type (2019-2032)
- 25.3. Market Revenue, by Application (2019-2032)
- 25.4. Market Revenue, by End User (2019-2032)
Chapter 26. Saudi Arabia Market
- 26.1. Overview
- 26.2. Market Revenue, by Product Type (2019-2032)
- 26.3. Market Revenue, by Application (2019-2032)
- 26.4. Market Revenue, by End User (2019-2032)
Chapter 27. South Africa Market
- 27.1. Overview
- 27.2. Market Revenue, by Product Type (2019-2032)
- 27.3. Market Revenue, by Application (2019-2032)
- 27.4. Market Revenue, by End User (2019-2032)
Chapter 28. U.A.E. Market
- 28.1. Overview
- 28.2. Market Revenue, by Product Type (2019-2032)
- 28.3. Market Revenue, by Application (2019-2032)
- 28.4. Market Revenue, by End User (2019-2032)
Chapter 29. Competitive Landscape
- 29.1. List of Market Players and their Offerings
- 29.2. Competitive Benchmarking of Key Players
- 29.3. Product Benchmarking of Key Players
- 29.4. Recent Strategic Developments
Chapter 30. Company Profiles
- 30.1. AbbVie Inc.
- 30.1.1. Business overview
- 30.1.2. Product and service offerings
- 30.1.3. Key financial summary
- 30.2. Arthrex Inc.
- 30.2.1. Business overview
- 30.2.2. Product and service offerings
- 30.2.3. Key financial summary
- 30.3. BioLife Solutions Inc.
- 30.3.1. Business overview
- 30.3.2. Product and service offerings
- 30.3.3. Key financial summary
- 30.4. TransMedics Inc.
- 30.4.1. Business overview
- 30.4.2. Product and service offerings
- 30.4.3. Key financial summary
- 30.5. Novartis AG
- 30.5.1. Business overview
- 30.5.2. Product and service offerings
- 30.5.3. Key financial summary
- 30.6. Teva Pharmaceuticals Industries Ltd.
- 30.6.1. Business overview
- 30.6.2. Product and service offerings
- 30.6.3. Key financial summary
- 30.7. Veloxis Pharmaceuticals A/S
- 30.7.1. Business overview
- 30.7.2. Product and service offerings
- 30.7.3. Key financial summary
- 30.8. Stryker Corporation
- 30.8.1. Business overview
- 30.8.2. Product and service offerings
- 30.8.3. Key financial summary
- 30.9. Zimmer Biomet Holdings Inc.
- 30.9.1. Business overview
- 30.9.2. Product and service offerings
- 30.9.3. Key financial summary
- 30.10. Dr. Franz Kohler Chemie GmbH
- 30.10.1. Business overview
- 30.10.2. Product and service offerings
- 30.10.3. Key financial summary
- 30.11. Paragonix Technologies Inc.
- 30.11.1. Business overview
- 30.11.2. Product and service offerings
- 30.11.3. Key financial summary
- 30.12. Smith & Nephew PLC
- 30.12.1. Business overview
- 30.12.2. Product and service offerings
- 30.12.3. Key financial summary
Chapter 31. Appendix
- 31.1. Abbreviations
- 31.2. Sources and References
- 31.3. Related Reports
